Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selcuk Ecza Deposu Ticaret venayi ASIST:SELEC +6.00%79 Return-on-Tangible-Asset is 6.97% as of Mar. 2026, which is 14% above its 10-year median of 6.14. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺88.37 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 118 Medical Distribution companies, Selcuk Ecza Deposu Ticaret venayi AS ranks worse than 63.56% on this metric.
The historical rank and industry rank for Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset or its related term are showing as below:
IST:SELEC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -0.45 Med: 6.14 Max: 9.38
Current: 1.49
During the past 13 years, Selcuk Ecza Deposu Ticaret venayi AS's highest Return-on-Tangible-Asset was 9.38%. The lowest was -0.45%. And the median was 6.14%.
IST:SELEC's Return-on-Tangible-Asset is ranked worse than 63.56% of 118
companies
in the Medical Distribution industry
Industry Median: 2.305
vs IST:SELEC: 1.49
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Asset Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Asset Chart
IST:SELEC vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.97% mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Return-on-Tangible-Asset of 6.97% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is 14% above median its historical median of 6.14. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #75 out of 118 companies in the Medical Distribution industry, placing it in the top 63.6%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Asset of 6.97% is 14% above median its 10-year median of 6.14. The Medical Distribution industry median Return-on-Tangible-Asset is 2.31. Selcuk Ecza Deposu Ticaret venayi AS's value of 6.97% is 202.4% above this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #75 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #75 out of 118 companies for Return-on-Tangible-Asset. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.31. Selcuk Ecza Deposu Ticaret venayi AS's value of 6.97% is 202.4% above this benchmark. While the company's 10-year median is 6.14 vs. the industry median of 2.31, Selcuk Ecza Deposu Ticaret venayi AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.31, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Asset of 6.97% is 202.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Asset is 6.97%, which is 14% above median its own 10-year median of 6.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺88.37, compared to a current price of ₺219.00 — trading 147.8% above its estimated fair value. The current Return-on-Tangible-Asset is 6.97%, which is 14% above median its 10-year median of 6.14 and 202.4% above the Medical Distribution industry median of 2.31. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Return-on-Tangible-Asset is 6.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺219.00 is trading 147.8% above its estimated GF Value™ of ₺88.37.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Return-on-Tangible-Asset: 6.97% (14% above median its 10-year median of 6.14)
GF Value™: ₺88.37 vs. price of ₺219.00 (147.8% above fair value)
Industry Position: 202.4% above the Medical Distribution median (#75 of 118)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score
Get the complete analysis for IST:SELEC
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
